HEADER PROTEIN BINDING 28-NOV-18 6IAY TITLE ALPHA-1-ANTITRYPSIN QUEEN'S (LYS154ASN) VARIANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1-ANTITRYPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ALPHA-1 PROTEASE INHIBITOR,ALPHA-1-ANTIPROTEINASE,SERPIN A1; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SERPINA1, AAT, PI, PRO0684, PRO2209; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: K12; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: XL-1 BLUE; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PQE30 KEYWDS ANTITRYPSIN, PROTEASE INHIBITOR, SERPIN, MUTANT, DEFICIENCY, PROTEIN KEYWDS 2 BINDING EXPDTA X-RAY DIFFRACTION AUTHOR I.ALDOBIYAN,D.A.LOMAS,J.A.IRVING REVDAT 2 24-JAN-24 6IAY 1 REMARK REVDAT 1 18-DEC-19 6IAY 0 JRNL AUTH I.ALDOBIYAN,J.A.IRVING,D.A.LOMAS JRNL TITL STRUCTURAL DETERMINANTS OF INSTABILITY IN JRNL TITL 2 ALPHA-1-ANTITRYPSIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13-2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.470 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 29795 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 1536 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.5108 - 4.2234 0.99 2719 137 0.1764 0.1905 REMARK 3 2 4.2234 - 3.3526 0.99 2624 149 0.1873 0.1988 REMARK 3 3 3.3526 - 2.9289 0.98 2596 142 0.2186 0.2517 REMARK 3 4 2.9289 - 2.6612 0.98 2598 130 0.2176 0.2951 REMARK 3 5 2.6612 - 2.4704 0.98 2588 115 0.2260 0.2432 REMARK 3 6 2.4704 - 2.3248 0.97 2510 145 0.2372 0.3341 REMARK 3 7 2.3248 - 2.2084 0.97 2553 150 0.2534 0.3072 REMARK 3 8 2.2084 - 2.1122 0.97 2533 145 0.2646 0.3259 REMARK 3 9 2.1122 - 2.0309 0.97 2527 131 0.2760 0.3063 REMARK 3 10 2.0309 - 1.9608 0.97 2535 121 0.3102 0.3250 REMARK 3 11 1.9608 - 1.8995 0.96 2476 171 0.3609 0.3693 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.30 REMARK 3 SHRINKAGE RADIUS : 1.20 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6IAY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1200013124. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAY-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : COMPOUND REFRACTIVE LENSES REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS 1.9.3-GB491019A-RELEASE REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.6.2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29809 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 43.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.51400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.2 REMARK 200 STARTING MODEL: 6I4V REMARK 200 REMARK 200 REMARK: PLATE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22.5% PEG 1500, 0.1M SPG (SUCCINATE REMARK 280 -PHOSPHATE-GLYCINE) PH 5.75, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.13250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.38150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.13250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.38150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -9 REMARK 465 ARG A -8 REMARK 465 GLY A -7 REMARK 465 SER A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 THR A 1 REMARK 465 ASP A 2 REMARK 465 PRO A 3 REMARK 465 GLN A 4 REMARK 465 GLY A 5 REMARK 465 ASP A 6 REMARK 465 ALA A 7 REMARK 465 ALA A 8 REMARK 465 GLN A 9 REMARK 465 LYS A 10 REMARK 465 THR A 11 REMARK 465 ASP A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 ASP A 17 REMARK 465 GLN A 18 REMARK 465 ASP A 19 REMARK 465 HIS A 20 REMARK 465 PRO A 21 REMARK 465 THR A 22 REMARK 465 PHE A 23 REMARK 465 THR A 345 REMARK 465 GLU A 346 REMARK 465 LYS A 394 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 25 CD CE NZ REMARK 470 HIS A 43 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 46 CG OD1 ND2 REMARK 470 GLU A 86 CD OE1 OE2 REMARK 470 GLU A 94 CD OE1 OE2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 ARG A 101 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 107 CG OD1 OD2 REMARK 470 GLN A 111 CG CD OE1 NE2 REMARK 470 LYS A 125 CE NZ REMARK 470 GLU A 132 CG CD OE1 OE2 REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 GLU A 151 CD OE1 OE2 REMARK 470 GLU A 162 CG CD OE1 OE2 REMARK 470 LYS A 163 CD CE NZ REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 ASP A 171 CG OD1 OD2 REMARK 470 LYS A 174 CG CD CE NZ REMARK 470 GLU A 175 CG CD OE1 OE2 REMARK 470 ARG A 178 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 179 CG OD1 OD2 REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 LYS A 193 CD CE NZ REMARK 470 LYS A 201 CE NZ REMARK 470 LYS A 233 CG CD CE NZ REMARK 470 LYS A 234 CE NZ REMARK 470 GLU A 257 CG CD OE1 OE2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 GLU A 279 CD OE1 OE2 REMARK 470 LYS A 310 CE NZ REMARK 470 GLU A 324 CG CD OE1 OE2 REMARK 470 LYS A 343 CD CE NZ REMARK 470 MET A 351 CG SD CE REMARK 470 LYS A 380 CE NZ REMARK 470 GLN A 393 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 51 119.05 -162.00 REMARK 500 ALA A 70 -136.24 59.98 REMARK 500 ASN A 81 35.84 71.05 REMARK 500 ASP A 107 52.31 -96.30 REMARK 500 ASN A 247 57.97 -114.47 REMARK 500 LYS A 343 -76.99 -139.43 REMARK 500 ASN A 390 110.29 -165.45 REMARK 500 THR A 392 51.81 -106.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GLY A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6I4V RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH 4,4-DIMETHYL-4-SILAPENTANE-1-SULFONIC REMARK 900 ACID (DSS) DBREF 6IAY A 2 394 UNP P01009 A1AT_HUMAN 26 418 SEQADV 6IAY MET A -9 UNP P01009 INITIATING METHIONINE SEQADV 6IAY ARG A -8 UNP P01009 EXPRESSION TAG SEQADV 6IAY GLY A -7 UNP P01009 EXPRESSION TAG SEQADV 6IAY SER A -6 UNP P01009 EXPRESSION TAG SEQADV 6IAY HIS A -5 UNP P01009 EXPRESSION TAG SEQADV 6IAY HIS A -4 UNP P01009 EXPRESSION TAG SEQADV 6IAY HIS A -3 UNP P01009 EXPRESSION TAG SEQADV 6IAY HIS A -2 UNP P01009 EXPRESSION TAG SEQADV 6IAY HIS A -1 UNP P01009 EXPRESSION TAG SEQADV 6IAY HIS A 0 UNP P01009 EXPRESSION TAG SEQADV 6IAY THR A 1 UNP P01009 EXPRESSION TAG SEQADV 6IAY ASN A 154 UNP P01009 LYS 178 ENGINEERED MUTATION SEQADV 6IAY SER A 232 UNP P01009 CYS 256 ENGINEERED MUTATION SEQRES 1 A 404 MET ARG GLY SER HIS HIS HIS HIS HIS HIS THR ASP PRO SEQRES 2 A 404 GLN GLY ASP ALA ALA GLN LYS THR ASP THR SER HIS HIS SEQRES 3 A 404 ASP GLN ASP HIS PRO THR PHE ASN LYS ILE THR PRO ASN SEQRES 4 A 404 LEU ALA GLU PHE ALA PHE SER LEU TYR ARG GLN LEU ALA SEQRES 5 A 404 HIS GLN SER ASN SER THR ASN ILE PHE PHE SER PRO VAL SEQRES 6 A 404 SER ILE ALA THR ALA PHE ALA MET LEU SER LEU GLY THR SEQRES 7 A 404 LYS ALA ASP THR HIS ASP GLU ILE LEU GLU GLY LEU ASN SEQRES 8 A 404 PHE ASN LEU THR GLU ILE PRO GLU ALA GLN ILE HIS GLU SEQRES 9 A 404 GLY PHE GLN GLU LEU LEU ARG THR LEU ASN GLN PRO ASP SEQRES 10 A 404 SER GLN LEU GLN LEU THR THR GLY ASN GLY LEU PHE LEU SEQRES 11 A 404 SER GLU GLY LEU LYS LEU VAL ASP LYS PHE LEU GLU ASP SEQRES 12 A 404 VAL LYS LYS LEU TYR HIS SER GLU ALA PHE THR VAL ASN SEQRES 13 A 404 PHE GLY ASP THR GLU GLU ALA ASN LYS GLN ILE ASN ASP SEQRES 14 A 404 TYR VAL GLU LYS GLY THR GLN GLY LYS ILE VAL ASP LEU SEQRES 15 A 404 VAL LYS GLU LEU ASP ARG ASP THR VAL PHE ALA LEU VAL SEQRES 16 A 404 ASN TYR ILE PHE PHE LYS GLY LYS TRP GLU ARG PRO PHE SEQRES 17 A 404 GLU VAL LYS ASP THR GLU GLU GLU ASP PHE HIS VAL ASP SEQRES 18 A 404 GLN VAL THR THR VAL LYS VAL PRO MET MET LYS ARG LEU SEQRES 19 A 404 GLY MET PHE ASN ILE GLN HIS SER LYS LYS LEU SER SER SEQRES 20 A 404 TRP VAL LEU LEU MET LYS TYR LEU GLY ASN ALA THR ALA SEQRES 21 A 404 ILE PHE PHE LEU PRO ASP GLU GLY LYS LEU GLN HIS LEU SEQRES 22 A 404 GLU ASN GLU LEU THR HIS ASP ILE ILE THR LYS PHE LEU SEQRES 23 A 404 GLU ASN GLU ASP ARG ARG SER ALA SER LEU HIS LEU PRO SEQRES 24 A 404 LYS LEU SER ILE THR GLY THR TYR ASP LEU LYS SER VAL SEQRES 25 A 404 LEU GLY GLN LEU GLY ILE THR LYS VAL PHE SER ASN GLY SEQRES 26 A 404 ALA ASP LEU SER GLY VAL THR GLU GLU ALA PRO LEU LYS SEQRES 27 A 404 LEU SER LYS ALA VAL HIS LYS ALA VAL LEU THR ILE ASP SEQRES 28 A 404 GLU LYS GLY THR GLU ALA ALA GLY ALA MET PHE LEU GLU SEQRES 29 A 404 ALA ILE PRO MET SER ILE PRO PRO GLU VAL LYS PHE ASN SEQRES 30 A 404 LYS PRO PHE VAL PHE LEU MET ILE GLU GLN ASN THR LYS SEQRES 31 A 404 SER PRO LEU PHE MET GLY LYS VAL VAL ASN PRO THR GLN SEQRES 32 A 404 LYS HET GLY A 401 5 HETNAM GLY GLYCINE FORMUL 2 GLY C2 H5 N O2 FORMUL 3 HOH *210(H2 O) HELIX 1 AA1 ILE A 26 SER A 45 1 20 HELIX 2 AA2 SER A 53 LEU A 66 1 14 HELIX 3 AA3 LYS A 69 LEU A 80 1 12 HELIX 4 AA4 PRO A 88 ASN A 104 1 17 HELIX 5 AA5 VAL A 127 LEU A 137 1 11 HELIX 6 AA6 ASP A 149 THR A 165 1 17 HELIX 7 AA7 GLU A 199 THR A 203 5 5 HELIX 8 AA8 LYS A 259 LEU A 267 1 9 HELIX 9 AA9 THR A 268 ASN A 278 1 11 HELIX 10 AB1 LEU A 299 LEU A 306 1 8 HELIX 11 AB2 THR A 309 SER A 313 5 5 SHEET 1 AA1 7 ILE A 50 PHE A 52 0 SHEET 2 AA1 7 PRO A 382 VAL A 388 -1 O LYS A 387 N ILE A 50 SHEET 3 AA1 7 PHE A 370 GLU A 376 -1 N PHE A 370 O VAL A 388 SHEET 4 AA1 7 ALA A 248 PRO A 255 -1 N PHE A 253 O VAL A 371 SHEET 5 AA1 7 SER A 237 LYS A 243 -1 N MET A 242 O ALA A 250 SHEET 6 AA1 7 THR A 214 SER A 232 -1 N SER A 232 O SER A 237 SHEET 7 AA1 7 GLU A 204 ASP A 211 -1 N GLU A 204 O MET A 220 SHEET 1 AA2 8 ILE A 50 PHE A 52 0 SHEET 2 AA2 8 PRO A 382 VAL A 388 -1 O LYS A 387 N ILE A 50 SHEET 3 AA2 8 PHE A 370 GLU A 376 -1 N PHE A 370 O VAL A 388 SHEET 4 AA2 8 ALA A 248 PRO A 255 -1 N PHE A 253 O VAL A 371 SHEET 5 AA2 8 SER A 237 LYS A 243 -1 N MET A 242 O ALA A 250 SHEET 6 AA2 8 THR A 214 SER A 232 -1 N SER A 232 O SER A 237 SHEET 7 AA2 8 ARG A 282 PRO A 289 -1 O ARG A 282 N PHE A 227 SHEET 8 AA2 8 GLU A 363 LYS A 365 1 O VAL A 364 N HIS A 287 SHEET 1 AA3 5 GLU A 141 VAL A 145 0 SHEET 2 AA3 5 LEU A 112 SER A 121 1 N LEU A 118 O PHE A 143 SHEET 3 AA3 5 PHE A 182 LYS A 191 -1 O PHE A 189 N THR A 113 SHEET 4 AA3 5 LYS A 331 ILE A 340 1 O LYS A 331 N LEU A 184 SHEET 5 AA3 5 LEU A 291 ASP A 298 -1 N ILE A 293 O LEU A 338 SITE 1 AC1 3 LYS A 365 ASN A 367 HOH A 586 CRYST1 114.265 38.763 89.712 90.00 104.13 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008752 0.000000 0.002202 0.00000 SCALE2 0.000000 0.025798 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011494 0.00000